These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32255303)

  • 1. MicroRNA-182 Suppresses Malignant Melanoma Proliferation by Targeting RECK.
    Ding J; Zhu X; Chen X; Guan J; Li H
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
    Pan Y; Liang H; Chen W; Zhang H; Wang N; Wang F; Zhang S; Liu Y; Zhao C; Yan X; Zhang J; Zhang CY; Gu H; Zen K; Chen X
    RNA Biol; 2015; 12(3):276-89. PubMed ID: 25826661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
    Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
    World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-544a Stimulates endometrial carcinoma growth via targeted inhibition of reversion-inducing cysteine-rich protein with Kazal motifs.
    Zheng WP; Meng FL; Wang LY
    Mol Cell Probes; 2020 Oct; 53():101572. PubMed ID: 32525042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [miR-25 promotes cell proliferation by targeting RECK in human cervical carcinoma HeLa cells].
    Qiu G; Fang B; Xin G; Wei Q; Yuan X; Wu D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):40-3. PubMed ID: 25575057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
    Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
    BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulated microRNA-30b-3p inhibits proliferation, invasion and migration of glioma cells via inactivation of the AKT signaling pathway by up-regulating RECK.
    Jian Y; Xu CH; Li YP; Tang B; Xie SH; Zeng EM
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31270250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miR-182 regulates the effect of RECK on gallbladder cancer.
    Zheng H; Wang JJ; Zhao LJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Mar; 26(9):933-946. PubMed ID: 32206004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma.
    Wang N; Zhang CQ; He JH; Duan XF; Wang YY; Ji X; Zang WQ; Li M; Ma YY; Wang T; Zhao GQ
    Dig Dis Sci; 2013 Jul; 58(7):1863-70. PubMed ID: 23504349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
    Su BB; Zhou SW; Gan CB; Zhang XN
    J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.
    Xin C; Buhe B; Hongting L; Chuanmin Y; Xiwei H; Hong Z; Lulu H; Qian D; Renjie W
    FEBS J; 2013 Feb; 280(3):855-66. PubMed ID: 23176145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-138 inhibits proliferation of cervical cancer cells by targeting c-Met.
    Li B; Yang XX; Wang D; Ji HK
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1109-14. PubMed ID: 27049264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [miR-181c promotes the migration and angiogenesis of human A549 cells via targeting inhibition of reversion-inducing cysteine-rich protein with Kazal motifs (RECK)].
    Liu C; Zhao F; Sun P; Han W; Hong M; Wu J; Zhang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Dec; 38(12):1084-1090. PubMed ID: 36585230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
    Long J; Menggen Q; Wuren Q; Shi Q; Pi X
    Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of tumour proliferation, migration and invasion by miR-92b in targeting RECK in osteosarcoma.
    Zhou Z; Wang Z; Wei H; Wu S; Wang X; Xiao J
    Clin Sci (Lond); 2016 Jun; 130(11):921-30. PubMed ID: 26993249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
    Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
    J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200b-3p accelerates progression of pituitary adenomas by negatively regulating expression of RECK.
    Wang X; Jia Y; Li Q; Yang Q; Liu Y; Wei B; Niu X; Zhang Y; Luo X; Zhao Z; Wang P
    Oncol Res; 2024; 32(5):933-941. PubMed ID: 38686051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.